DRTS – alpha tau medical ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
Alpha Tau Medical Ltd. (NASDAQ: DRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Deadly cancer type linked to obesity and high stress levels [FOX News]
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
Alpha Tau to Participate in March Investor Conferences [Yahoo! Finance]
Form 6-K Alpha Tau Medical Ltd. For: Apr 02
Form S-8 Alpha Tau Medical Ltd.
Form 6-K Alpha Tau Medical Ltd. For: Mar 12
Form 20-F Alpha Tau Medical Ltd. For: Dec 31
Form 6-K Alpha Tau Medical Ltd. For: Feb 27
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.